Central Nervous System
Purchase our central nervous system module on a standalone basis or together with other modules and solutions across our full portfolio to create an integrated, tailor-made research platform.
Some of the best-selling drugs in history, such as Prozac, have treated central nervous system (CNS) conditions. In more recent times, however, CNS research has been more about frustration than profit, for pharmaceutical development.
The recent high-profile failure of drugs designed to treat Alzheimer’s disease, for example, has underscored the difficulty in treating neurological conditions. Despite the hindrances, an aging global population, coupled with large unmet needs, will only increase the market potential for therapies that do prove efficacious.
GlobalData's therapy module includes coverage from prevalent diseases such as depression to niche indications such as amyotrophic lateral sclerosis (ALS).